StockWatch
·

Aarti Pharmalabs Ltd Q4 FY25 Results

AARTIPHARMQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue563.784.8%
Total Income562.173.6%
Expenditure447.551.2%
PBT114.6213.9%
Net Profit88.3419.4%
OPM25.83%14.19pp
NPM15.71%2.08pp
EPS9.7519.5%
View full financials

Informational and educational content only. Not investment advice.